BioLife Solutions
BLFS
49 hedge funds and large institutions have $51.9M invested in BioLife Solutions in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 1 closing their positions.
1,900% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 1
501% more capital invested
Capital invested by funds: $8.62M → $51.9M (+$43.2M)
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
63% more funds holding
Funds holding: 30 → 49 (+19)
18.18% more ownership
Funds ownership: 11.9% → 30.09% (+18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$9.1M |
| 2 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
+$4.27M |
| 3 |
Renaissance Technologies
New York
|
+$1.63M |
| 4 |
SCM
Sandler Capital Management
New York
|
+$1.38M |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$802K |
| 2 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$152K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$151K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$33.1K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$6.69K |
BLFS Hedge Fund Activity: Q2 2018 in Review
49 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2018, worth a combined $51.9M — up 501% from $8.62M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new BLFS positions and 1 closed out — a net gain of 19 holders — while 16 added to existing stakes and 5 trimmed.
The largest buyer was Casdin Capital, opening a new position worth an estimated $9.1M. The largest seller was Millennium Management, cutting an estimated $802K.
- 49 institutional investors held BioLife Solutions (BLFS) as of Q2 2018, up from 30 in Q1 2018.
- Funds reported $51.9M of BioLife Solutions stock for Q2 2018, up 501% quarter-over-quarter.
- 20 funds opened new BioLife Solutions positions in Q2 2018 and 1 closed out, a net change of +19 holders.
- The largest BioLife Solutions buyer in Q2 2018 was Casdin Capital, an estimated $9.1M added.
- The largest BioLife Solutions seller in Q2 2018 was Millennium Management, an estimated $802K sold.
Based on aggregated 13F filings for Q2 2018.